BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 17537192)

  • 41. The concept of perihilar cholangiocarcinoma is valid.
    Ebata T; Kamiya J; Nishio H; Nagasaka T; Nimura Y; Nagino M
    Br J Surg; 2009 Aug; 96(8):926-34. PubMed ID: 19591162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multivariate analysis by Cox Proportional Hazards Model on prognoses of patients with bile duct carcinoma after resection.
    He P; Shi J; Chen W; Wang Z
    Chin Med J (Engl); 2002 Oct; 115(10):1538-41. PubMed ID: 12490105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma.
    Ramacciato G; Mercantini P; Cautero N; Corigliano N; Di Benedetto F; Quintini C; Ercolani G; Varotti G; Ziparo V; Pinna AD
    Ann Surg Oncol; 2005 Apr; 12(4):289-97. PubMed ID: 15827681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma.
    Nozaki Y; Yamamoto M; Ikai I; Yamamoto Y; Ozaki N; Fujii H; Nagahori K; Matsumoto Y; Yamaoka Y
    Cancer; 1998 Nov; 83(9):1923-9. PubMed ID: 9806650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome.
    Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S
    Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Kinoshita H
    Br J Surg; 2001 Jul; 88(7):969-74. PubMed ID: 11442529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
    Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
    J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 51. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
    Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.
    Gomez D; Morris-Stiff G; Toogood GJ; Lodge JP; Prasad KR
    J Surg Oncol; 2008 May; 97(6):513-8. PubMed ID: 18335453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
    Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
    J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
    [No Abstract]   [Full Text] [Related]  

  • 55. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
    Yano Y; Yamamoto J; Kosuge T; Sakamoto Y; Yamasaki S; Shimada K; Ojima H; Sakamoto M; Takayama T; Makuuchi M
    Jpn J Clin Oncol; 2003 Jun; 33(6):283-7. PubMed ID: 12913082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synchronous carcinoma of the gallbladder in a patient with intrahepatic bile duct carcinoma.
    Taniai N; Onda M; Tajiri T; Yoshida H; Naitou Z
    Hepatogastroenterology; 2000; 47(31):121-4. PubMed ID: 10690592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Technical aspects of segment I resection of the liver].
    Ringe B; Canelo R; Schulze FP; Lorf T
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():269-71. PubMed ID: 9101852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.